Although it is widely known that uPA plays important roles in PC cell invasion and proliferation[9,15], the classical aspect of uPA as an activator of the fibrinolytic system may paradoxically not be easily conceivable in patients with PC with bleeding disorder. This evidence concerns the gene PLAU and hemorrhagic disease.